169 related articles for article (PubMed ID: 35753213)
1. Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis.
Mai AS; Lee ARYB; Tay RYK; Shapiro L; Thakkar A; Halmos B; Grinshpun A; Herishanu Y; Benjamini O; Tadmor T; Shroff RT; LaFleur BJ; Bhattacharya D; Peng S; Tey J; Lee SC; Chai LYA; Soon YY; Sundar R; Lee MX
Eur J Cancer; 2022 Sep; 172():65-75. PubMed ID: 35753213
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review.
Al Hajji Y; Taylor H; Starkey T; Lee LYW; Tilby M
Br J Cancer; 2022 Nov; 127(10):1827-1836. PubMed ID: 36224402
[TBL] [Abstract][Full Text] [Related]
4. Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety.
Lee ARYB; Wong SY; Tay SH
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632424
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Tran S; Truong TH; Narendran A
Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
[TBL] [Abstract][Full Text] [Related]
6. Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres.
Šušol O; Hájková B; Zelená H; Hájek R
Br J Haematol; 2022 May; 197(3):302-305. PubMed ID: 35076937
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
Yin J; Chen Y; Li Y; Wang C; Zhang X
Int J Infect Dis; 2022 Nov; 124():212-223. PubMed ID: 36241168
[TBL] [Abstract][Full Text] [Related]
8. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.
Mehrabi Nejad MM; Shobeiri P; Dehghanbanadaki H; Tabary M; Aryannejad A; Haji Ghadery A; Shabani M; Moosaie F; SeyedAlinaghi S; Rezaei N
Virol J; 2022 Aug; 19(1):132. PubMed ID: 35941646
[TBL] [Abstract][Full Text] [Related]
9. Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies.
Ollila TA; Masel RH; Reagan JL; Lu S; Rogers RD; Paiva KJ; Taher R; Burguera-Couce E; Zayac AS; Yakirevich I; Niroula R; Barth P; Olszewski AJ
Cancer; 2022 Sep; 128(18):3319-3329. PubMed ID: 35811461
[TBL] [Abstract][Full Text] [Related]
10. Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis.
Yin J; Chen Y; Li Y; Zhang X; Wang C
Hum Vaccin Immunother; 2022 Nov; 18(6):2119763. PubMed ID: 36161976
[TBL] [Abstract][Full Text] [Related]
11. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.
Reimann P; Ulmer H; Mutschlechner B; Benda M; Severgnini L; Volgger A; Lang T; Atzl M; Huynh M; Gasser K; Grabher C; Mink S; Fraunberger P; Petrausch U; Hartmann B; Winder T
Br J Haematol; 2022 Feb; 196(3):577-584. PubMed ID: 34872162
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis.
Flacco ME; Manzoli L; Rosso A; Marzuillo C; Bergamini M; Stefanati A; Cultrera R; Villari P; Ricciardi W; Ioannidis JPA; Contopoulos-Ioannidis DG
Lancet Infect Dis; 2018 Apr; 18(4):461-472. PubMed ID: 29371070
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews.
Sun H; Bu F; Li L; Zhang X; Yan J; Huang T
Front Public Health; 2022; 10():1072137. PubMed ID: 36457318
[TBL] [Abstract][Full Text] [Related]
16. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
Front Immunol; 2022; 13():940562. PubMed ID: 36091023
[TBL] [Abstract][Full Text] [Related]
17. Immunity waning after COVID vaccine booster
Khoury J; Najjar-Debbiny R; Elemy A; Jabbour A; Haj J; Abu-Sini M; Yasin R; Amin M; Hellou E; Nasrallah N; Saffouri A; Hakim F
Infect Dis (Lond); 2022 Nov; 54(11):828-831. PubMed ID: 35796285
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
Sakuraba A; Luna A; Micic D
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
[TBL] [Abstract][Full Text] [Related]
19. Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
Ferri C; Gragnani L; Raimondo V; Visentini M; Giuggioli D; Lorini S; Foti R; Cacciapaglia F; Caminiti M; Olivo D; Cuomo G; Pellegrini R; Pigatto E; Urraro T; Naclerio C; Tavoni A; Puccetti L; Cavazzana I; Ruscitti P; Vadacca M; La Gualana F; Cozzi F; Spinella A; Visalli E; Bosco YD; Amato G; Masini F; Mariano GP; Brittelli R; Aiello V; Scorpiniti D; Rechichi G; Varcasia G; Monti M; Elia G; Franceschini F; Casato M; Ursini F; Giacomelli R; Fallahi P; Santini SA; Iannone F; Salvarani C; Zignego AL; Antonelli A
J Autoimmun; 2022 Jul; 131():102866. PubMed ID: 35841684
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis.
Li Z; Liu S; Li F; Li Y; Li Y; Peng P; Li S; He L; Liu T
Front Immunol; 2022; 13():965971. PubMed ID: 36177017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
